Cubist Systematic Strategies, LLC Taro Pharmaceutical Industries LTD Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $1,756 - $1,916	-25 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $1,762 - $1,998	25 New	25 $2,000
Q4 2019 Feb 14, 2020	SELL	$74.18 - $97.92 $200,137 - $264,188	-2,698 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$75.36 - $86.57 $104,373 - $119,899	-1,385 Reduced 33.92%	2,698 $204,000
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $130,579 - $169,417	1,556 Added 61.57%	4,083 $349,000
Q1 2019 May 15, 2019	BUY	$85.97 - $108.09 $5,502 - $6,917	64 Added 2.6%	2,527 $273,000
Q4 2018 Feb 14, 2019	BUY	$78.25 - $107.92 $24,179 - $33,347	309 Added 14.35%	2,463 $208,000
Q3 2018 Nov 14, 2018	SELL	$97.82 - $116.09 $192,509 - $228,465	-1,968 Reduced 47.74%	2,154 $212,000
Q2 2018 Aug 14, 2018	SELL	$97.62 - $120.59 $67,943 - $83,930	-696 Reduced 14.45%	4,122 $477,000
Q1 2018 May 15, 2018	SELL	$95.91 - $107.26 $532,780 - $595,829	-5,555 Reduced 53.55%	4,818 $476,000
Q4 2017 Feb 14, 2018	BUY	$104.5 - $126.38 $1.08 Million - $1.31 Million	10,373	10,373 $1.09 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.